I-Pei Wu

The ALBI grade predicts the prognosis of patients with advanced hepatocellular carcinoma received sorafenib

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2017 .

The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2018, Investigational New Drugs.

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

K. Rau, Sheng-Nan Lu, Chien-Hung Chen, 2017, Journal of gastroenterology and hepatology.